Biontech plans to produce mRNA vaccines in Africa

In an attempt to address covid-19 and a number of other widespread diseases in Africa, Biontech plans to establish a factory there for the production of mRNA vaccines.
Biontech CEO and co-founder Ugur Sahin | Photo: Biontech / PR
Biontech CEO and co-founder Ugur Sahin | Photo: Biontech / PR
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN

Biontech plans to expand its production to Africa by establishing an mRNA vaccine factory to combat widespread diseases including covid-19.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading